some of which will potentially be used to accelerate the development of next-generation product candidates targeting multiple ...

BeiGene, Ltd. (NASDAQ:BGNE – Get Free Report)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $193.29, but opened at $187.79. BeiGene shares last ...

We all have insecure moments, but when feeling insecure is something you think about all the time, you need to take action.

Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

Co-owner of Burlington’s Finnigan’s Pub for more than 32 years was known for his work ethic, great attitude and remarkable ...

Don M. Benson, MD, PhD, has cared for patients at James Cancer Hospital in Ohio for 22 years, where he and his team see approximately 10,000 patient visits each year.

In the end, all I could say is I have been there through sickness and your darkest times, and he didn’t say anything. I told ...

High rates of overall response and MRD negativity were seen regardless of the dose patients received, said Andrew Spencer, MBBS.

Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...

GSK has announced positive headline interim analysis outcomes from a Phase III trial, which is evaluating Blenrep (belantamab ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...